RPTX241018C7500
- 0.50
- 0.000.00%
Repare Therapeutics Newsroom
LifeSci Capital Maintains Repare Therapeutics(RPTX.US) With Buy Rating, Maintains Target Price $8
Piper Sandler Maintains Repare Therapeutics(RPTX.US) With Buy Rating, Maintains Target Price $25
Stifel Maintains Repare Therapeutics(RPTX.US) With Buy Rating, Maintains Target Price $9
Stifel Nicolaus Keeps Their Buy Rating on Repare Therapeutics (RPTX)
Morgan Stanley Maintains Repare Therapeutics(RPTX.US) With Hold Rating, Maintains Target Price $8
Hold Rating on Repare Therapeutics Amidst Early Promising Clinical Results and Safety Concerns
HC Wainwright & Co. Reiterates Buy on Repare Therapeutics, Maintains $10 Price Target
Repare Therapeutics Analyst Ratings
H.C. Wainwright Maintains Repare Therapeutics(RPTX.US) With Buy Rating, Maintains Target Price $10
Piper Sandler Maintains Repare Therapeutics(RPTX.US) With Buy Rating, Maintains Target Price $25
Piper Sandler Sticks to Its Buy Rating for Repare Therapeutics (RPTX)
Bloom Burton Maintains Repare Therapeutics(RPTX.US) With Buy Rating, Maintains Target Price $15
Hold Rating on Repare Therapeutics Awaits Key Clinical Data and Market Potential Realization
Morgan Stanley Maintains Repare Therapeutics(RPTX.US) With Hold Rating, Maintains Target Price $8
Repare Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.
Repare Therapeutics Analyst Ratings
H.C. Wainwright Maintains Repare Therapeutics(RPTX.US) With Buy Rating, Maintains Target Price $10
LifeSci Capital Maintains Repare Therapeutics(RPTX.US) With Buy Rating, Maintains Target Price $8
Analysts' Opinions Are Mixed on These Healthcare Stocks: Walgreens Boots Alliance (WBA), 2seventy Bio (TSVT) and Repare Therapeutics (RPTX)
Stifel Nicolaus Reaffirms Their Buy Rating on Repare Therapeutics (RPTX)